ESMO highlights from Prof Gordon McVie - his views on the science presented

The ESMO President discusses the congress and future plans for developing countries

The role of EORTC - clinical trials, translational research, molecular trials and more

The importance of a multi-disciplinary approach to the development of cancer treatments

The role of the B-RAF mutation in melanoma treatment

The potential of epigenetics in cancer treatment

The role of homologous recombination in cancer

The role of epigenetics in cancer therapy

The development of novel targets for cancer therapy

Communication skills in clinical practice

Patient uptake in clinical trials

Costs and benefits of bone metastases therapies